Rockefeller Capital Management L.P. Cuts Stock Position in Masimo Corporation $MASI

Rockefeller Capital Management L.P. trimmed its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 41.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,411 shares of the medical equipment provider’s stock after selling 61,017 shares during the quarter. Rockefeller Capital Management L.P. owned approximately 0.16% of Masimo worth $11,239,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. American Century Companies Inc. increased its stake in shares of Masimo by 10.6% during the third quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider’s stock worth $24,839,000 after purchasing an additional 16,113 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Masimo by 1.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock worth $346,464,000 after buying an additional 43,915 shares during the last quarter. Citigroup Inc. boosted its holdings in Masimo by 133.5% in the 3rd quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider’s stock worth $17,215,000 after buying an additional 66,710 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Masimo by 483.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 11,371 shares of the medical equipment provider’s stock worth $1,561,000 after buying an additional 9,423 shares in the last quarter. Finally, Tudor Investment Corp ET AL purchased a new stake in Masimo during the 3rd quarter worth approximately $4,669,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Performance

NASDAQ MASI opened at $179.95 on Thursday. The stock has a market cap of $9.42 billion, a PE ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $179.99. The stock has a fifty day simple moving average of $178.93 and a 200-day simple moving average of $162.74. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Weiss Ratings upgraded Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Wells Fargo & Company raised Masimo to a “hold” rating in a research note on Wednesday, March 18th. Finally, Raymond James Financial lowered Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Nine analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Masimo has a consensus rating of “Hold” and an average price target of $180.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.